JET Product Publication: Published in a Q1 Journal under Gynecologist Guidance
DOI: 10.3390/jcm15041395. Negative culture rates improved from 40% to 80% in the JET group, while vaginal discharge findings dropped from 96.7% to 6.9%.
2026MDPI Journal of Clinical Medicine (Q1)DOI: 10.3390/jcm15041395